Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03149822
Title Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

renal cell carcinoma

Therapies

Cabozantinib + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Denver Aurora Colorado 80045 United States Details
Memorial Hospital Central Colorado Springs Colorado 80909 United States Details
Poudre Valley Hospital Fort Collins Colorado 80528 United States Details
Highlands Ranch Hospital Highlands Ranch Colorado 80129 United States Details
UCHealth Lone Tree Medical Center Lone Tree Colorado 80124 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field